Literature DB >> 21610670

Seven steps to stellate cells.

Patrick Maschmeyer1, Melanie Flach, Florian Winau.   

Abstract

Hepatic stellate cells are liver-resident cells of star-like morphology and are located in the space of Disse between liver sinusoidal endothelial cells and hepatocytes(1,2). Stellate cells are derived from bone marrow precursors and store up to 80% of the total body vitamin A(1, 2). Upon activation, stellate cells differentiate into myofibroblasts to produce extracellular matrix, thus contributing to liver fibrosis(3). Based on their ability to contract, myofibroblastic stellate cells can regulate the vascular tone associated with portal hypertension(4). Recently, we demonstrated that hepatic stellate cells are potent antigen presenting cells and can activate NKT cells as well as conventional T lymphocytes(5). Here we present a method for the efficient preparation of hepatic stellate cells from mouse liver. Due to their perisinusoidal localization, the isolation of hepatic stellate cells is a multi-step process. In order to render stellate cells accessible to isolation from the space of Disse, mouse livers are perfused in situ with the digestive enzymes Pronase E and Collagenase P. Following perfusion, the liver tissue is subjected to additional enzymatic treatment with Pronase E and Collagenase P in vitro. Subsequently, the method takes advantage of the massive amount of vitamin A-storing lipid droplets in hepatic stellate cells. This feature allows the separation of stellate cells from other hepatic cell types by centrifugation on an 8% Nycodenz gradient. The protocol described here yields a highly pure and homogenous population of stellate cells. Purity of preparations can be assessed by staining for the marker molecule glial fibrillary acidic protein (GFAP), prior to analysis by fluorescence microscopy or flow cytometry. Further, light microscopy reveals the unique appearance of star-shaped hepatic stellate cells that harbor high amounts of lipid droplets. Taken together, we present a detailed protocol for the efficient isolation of hepatic stellate cells, including representative images of their morphological appearance and GFAP expression that help to define the stellate cell entity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21610670      PMCID: PMC3197116          DOI: 10.3791/2710

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  7 in total

Review 1.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

2.  Ito cells are liver-resident antigen-presenting cells for activating T cell responses.

Authors:  Florian Winau; Guido Hegasy; Ralf Weiskirchen; Stephan Weber; Cécile Cassan; Peter A Sieling; Robert L Modlin; Roland S Liblau; Axel M Gressner; Stefan H E Kaufmann
Journal:  Immunity       Date:  2007-01       Impact factor: 31.745

3.  Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair.

Authors:  T Knittel; D Kobold; F Piscaglia; B Saile; K Neubauer; M Mehde; R Timpl; G Ramadori
Journal:  Histochem Cell Biol       Date:  1999-11       Impact factor: 4.304

Review 4.  History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells.

Authors:  A Geerts
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

5.  Gene expression profiles during hepatic stellate cell activation in culture and in vivo.

Authors:  Samuele De Minicis; Ekihiro Seki; Hiroshi Uchinami; Johannes Kluwe; Yonghui Zhang; David A Brenner; Robert F Schwabe
Journal:  Gastroenterology       Date:  2007-02-21       Impact factor: 22.682

Review 6.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 7.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

  7 in total
  29 in total

1.  IGFBP7 Deletion Promotes Hepatocellular Carcinoma.

Authors:  Maaged Akiel; Chunqing Guo; Xia Li; Devaraja Rajasekaran; Rachel G Mendoza; Chadia L Robertson; Nidhi Jariwala; Fang Yuan; Mark A Subler; Jolene Windle; Dawn K Garcia; Zhao Lai; Hung-I Harry Chen; Yidong Chen; Shah Giashuddin; Paul B Fisher; Xiang-Yang Wang; Devanand Sarkar
Journal:  Cancer Res       Date:  2017-06-15       Impact factor: 12.701

2.  Inhibition of Mastermind-like 1 alleviates liver fibrosis induced by carbon tetrachloride in rats.

Authors:  Shaoping Zheng; Yixiong Chen; Shaojiang Zheng; Zhihui He; Zhihong Weng
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-06

3.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

4.  Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis.

Authors:  Benjamin Pulli; Muhammad Ali; Yoshiko Iwamoto; Matthias W G Zeller; Stefan Schob; Jenny J Linnoila; John W Chen
Journal:  Antioxid Redox Signal       Date:  2015-06-24       Impact factor: 8.401

5.  Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice.

Authors:  Rinku Dutta; Virender Kumar; Yang Peng; Ruby E Evande; Jean L Grem; Ram I Mahato
Journal:  Pharm Res       Date:  2016-12-19       Impact factor: 4.200

6.  Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis.

Authors:  Jie Luo; Yuejin Liang; Fanping Kong; Jingfan Qiu; Xinjian Liu; Ailing Chen; Bruce A Luxon; Hannah W Wu; Yong Wang
Journal:  Immunol Cell Biol       Date:  2016-11-03       Impact factor: 5.126

7.  Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.

Authors:  Hiroyuki Kato; Sergio Duarte; Mary G Miller; Ronald W Busuttil; Ana J Coito
Journal:  Liver Transpl       Date:  2019-02       Impact factor: 5.799

8.  Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.

Authors:  Jung Il Lee; Jocelyn H Wright; Melissa M Johnson; Renay L Bauer; Kristina Sorg; Sebastian Yuen; Brian J Hayes; Lananh Nguyen; Kimberly J Riehle; Jean S Campbell
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-02       Impact factor: 4.249

9.  Isolation and Culture of Murine Hepatic Stellate Cells.

Authors:  Rucha V Modak; Dietmar M Zaiss
Journal:  Bio Protoc       Date:  2019-11-05

10.  Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis.

Authors:  Chongshu Jian; Jiajun Fu; Xu Cheng; Li-Jun Shen; Yan-Xiao Ji; Xiaoming Wang; Shan Pan; Han Tian; Song Tian; Rufang Liao; Kehan Song; Hai-Ping Wang; Xin Zhang; Yibin Wang; Zan Huang; Zhi-Gang She; Xiao-Jing Zhang; Lihua Zhu; Hongliang Li
Journal:  Cell Metab       Date:  2020-05-05       Impact factor: 31.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.